- Home
- SNPX vs LFLY Comparison
SNPX vs LFLY Comparison
Compare SNPX & LFLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNPX
- LFLY
- Stock Information
- Founded
- SNPX 2012
- LFLY 2010
- Country
- SNPX United States
- LFLY United States
- Employees
- SNPX 5
- LFLY N/A
- Industry
- SNPX Medicinal Chemicals and Botanical Products
- LFLY Computer Software: Prepackaged Software
- Sector
- SNPX Health Care
- LFLY Technology
- Exchange
- SNPX Nasdaq
- LFLY Nasdaq
- Market Cap
- SNPX 3.7M
- LFLY 3.9M
- IPO Year
- SNPX N/A
- LFLY N/A
- Fundamental
- Price
- SNPX $2.69
- LFLY $1.21
- Analyst Decision
- SNPX Strong Buy
- LFLY Strong Buy
- Analyst Count
- SNPX 1
- LFLY 2
- Target Price
- SNPX $14.00
- LFLY $7.59
- AVG Volume (30 Days)
- SNPX 13.4K
- LFLY 32.7K
- Earning Date
- SNPX 11-12-2024
- LFLY 11-07-2024
- Dividend Yield
- SNPX N/A
- LFLY N/A
- EPS Growth
- SNPX N/A
- LFLY N/A
- EPS
- SNPX N/A
- LFLY N/A
- Revenue
- SNPX N/A
- LFLY $35,868,000.00
- Revenue This Year
- SNPX N/A
- LFLY N/A
- Revenue Next Year
- SNPX N/A
- LFLY N/A
- P/E Ratio
- SNPX N/A
- LFLY N/A
- Revenue Growth
- SNPX N/A
- LFLY N/A
- 52 Week Low
- SNPX $2.32
- LFLY $1.20
- 52 Week High
- SNPX $8.78
- LFLY $5.88
- Technical
- Relative Strength Index (RSI)
- SNPX 45.01
- LFLY 34.88
- Support Level
- SNPX $2.52
- LFLY $1.20
- Resistance Level
- SNPX $2.80
- LFLY $1.35
- Average True Range (ATR)
- SNPX 0.21
- LFLY 0.08
- MACD
- SNPX -0.01
- LFLY 0.00
- Stochastic Oscillator
- SNPX 33.32
- LFLY 16.92
About SNPX Synaptogenix Inc.
Synaptogenix Inc is a biopharmaceutical company with product candidates in pre-clinical and clinical development. It is principally focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease, which is in the clinical testing stage. It is also evaluating bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis, and Niemann-Pick Type C disease, which have undergone pre-clinical testing.
About LFLY Leafly Holdings Inc.
Leafly Holdings Inc operates an online cannabis information resource platform. It offers cannabis retailers and brands subscription-based marketplace listings that provide its cannabis audience with information, reviews, menus, and ordering and delivery options through legal retailers.